Newsroom

Date   Title
Feb 22, 2017   Meso Scale Discovery Launches New V-PLEX® Assays for Th17 Research

   
August 30, 2016   Meso Scale Discovery Launches α-Synuclein Assay for Parkinson’s Disease Research

   
June 8, 2015   Meso Scale Discovery Launches Its New Services for the Acceleration of Biomarker Research

   
February 18, 2015   Meso Scale Discovery Launches Its New U-PLEX Platform for Personalized Immunoassay Multiplexing  

   
January 15, 2015   PreClinOmics: New Validated Mouse Biomarker Panel from Meso Scale Discovery

   
May 23, 2014   MSD Biomarker Assays Selected for Resveratrol Study in Alzheimer’s Disease

   
May 21, 2014   Meso Scale Discovery Introduces Its New S-PLEX High-Sensitivity Biomarker Immunoassay Technology

   
March 5, 2014   BioAgilytix Becomes the First CRO to Validate Meso Scale Discovery’s V-PLEX Human Cytokine 30-Plex Assay

   
November 25, 2013   Alliance Pharma has successfully completed testing and validation of the Meso Scale Discovery (MSD) Human V-PLEX Aβ Peptide Panel 1 Assay (6E10)

   
October 25, 2013   MPI Research: Leading the Way for Biomarker Sample Analysis for Proinflammatory Cytokines in Mice Using MSD V-PLEX Immunoassays

   
September 11, 2013   Meso Scale Discovery Launches V-PLEX Multiplex Biomarker Immunoassays

   
July 17, 2013   Meso Scale Discovery Launches New QuickPlex SQ 120 Multiplex Immunoassay Instrument

   
August 3, 2012   Meso Scale Diagnostics Announces ISO 9001:2008 and ISO 13485:2003 Certifications

   
March 28, 2012   Bristol-Myers Squibb and MESO SCALE DISCOVERY Enter Agreement to Develop Diagnostic Assays for Alzheimer's Disease

   
October 27, 2011   Biomed Realty Trust and MESO SCALE DIAGNOSTICS Announce 104,700 Square Foot Lease at 1701 Research Boulevard in Maryland

   
May 4, 2009   MESO SCALE DIAGNOSTICS' Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection
     
Customer Service/Orders


Scientific/Technical Support


Instrument Support


Company Headquarters